In a meeting held earlier this month with Niti Aayog, DoP also suggested that trade margin on all formulations and dosages be capped at 100%.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2mtwvvQ
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» DoP lists options to rationalise drug trade margins for Niti Aayog
0 comments:
Post a Comment